Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33485119)

  • 1. Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected-macrophages activation.
    Katebi A; Varshochian R; Riazi-Rad F; Ganjalikhani-Hakemi M; Ajdary S
    Biomed Pharmacother; 2021 May; 137():111276. PubMed ID: 33485119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-nitrochalcone exerts leishmanicidal effect on L. amazonensis promastigotes and intracellular amastigotes, and the 4-nitrochalcone encapsulation in beeswax copaiba oil nanoparticles reduces macrophages cytotoxicity.
    Assolini JP; da Silva TP; da Silva Bortoleti BT; Gonçalves MD; Tomiotto-Pellissier F; Sahd CS; Carloto ACM; Feuser PE; Cordeiro AP; Sayer C; Hermes de Araújo PH; Costa IN; Conchon-Costa I; Miranda-Sapla MM; Pavanelli WR
    Eur J Pharmacol; 2020 Oct; 884():173392. PubMed ID: 32735985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
    Rostamian M; Niknam HM
    Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    Rostamian M; Bahrami F; Niknam HM
    PLoS One; 2018; 13(9):e0204491. PubMed ID: 30248142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania.
    Santos DM; Carneiro MW; de Moura TR; Soto M; Luz NF; Prates DB; Irache JM; Brodskyn C; Barral A; Barral-Netto M; Espuelas S; Borges VM; de Oliveira CI
    Nanomedicine; 2013 Oct; 9(7):985-95. PubMed ID: 23603355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance Against
    Lopes ME; Dos Santos LM; Sacks D; Vieira LQ; Carneiro MB
    Front Immunol; 2021; 12():730437. PubMed ID: 34745100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: Evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis.
    Tosyali OA; Allahverdiyev A; Bagirova M; Abamor ES; Aydogdu M; Dinparvar S; Acar T; Mustafaeva Z; Derman S
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111684. PubMed ID: 33545846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
    Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
    Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
    Lakhal-Naouar I; Koles N; Rao M; Morrison EB; Childs JM; Alving CR; Aronson NE
    Vaccine; 2019 Jan; 37(3):516-523. PubMed ID: 30528328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles Loaded with a New Thiourea Derivative: Development and
    Meireles PW; de Souza DPB; Rezende MG; Borsodi MPG; de Oliveira DE; da Silva LCRP; de Souza AMT; Viana GM; Rodrigues CR; do Carmo FA; de Sousa VP; Rossi-Bergmann B; Cabral LM
    Curr Drug Deliv; 2020; 17(8):694-702. PubMed ID: 32621717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J; Moreno E; Calvo A; Blanco L; Fernández-Rubio C; Sanmartín C; Nguewa P; Irache JM; Larrea E; Espuelas S
    J Dermatol Sci; 2018 Oct; 92(1):78-88. PubMed ID: 30037731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR9-deficiency reduces TLR1, TLR2 and TLR3 expressions in Leishmania major-infected macrophages.
    Pandey SP; Doyen N; Mishra GC; Saha B; Chandel HS
    Exp Parasitol; 2015 Jul; 154():82-6. PubMed ID: 25911242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fe3O4
    Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
    Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cytokine Network Balance Influences the Fate of
    Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
    Front Immunol; 2021; 12():656919. PubMed ID: 34276650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages.
    Maksouri H; Dang PM; Rodrigues V; Estaquier J; Riyad M; Akarid K
    Parasit Vectors; 2017 Oct; 10(1):506. PubMed ID: 29061164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy downstream of endosomal Toll-like receptor signaling in macrophages is a key mechanism for resistance to
    Franco LH; Fleuri AKA; Pellison NC; Quirino GFS; Horta CV; de Carvalho RVH; Oliveira SC; Zamboni DS
    J Biol Chem; 2017 Aug; 292(32):13087-13096. PubMed ID: 28607148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.